These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of pharmacotherapy in secondary prevention of myocardial infarction and death. Gorlin R; Fuster V Mt Sinai J Med; 1984 Jun; 51(3):229-36. PubMed ID: 6146929 [No Abstract] [Full Text] [Related]
4. [Beta-blockers and secondary prevention after myocardial infarction]. Kher A; Jaillon P Therapie; 1984; 39(2):189-96. PubMed ID: 6145232 [No Abstract] [Full Text] [Related]
5. [Secondary prevention after myocardial infarction--beta blockade and acetylsalicylic acid is the basic therapy]. Bergstrand R; Johansson S; Ulvenstam G; Aberg A; Wilhelmsen L Lakartidningen; 1989 Jan; 86(1-2):47-50. PubMed ID: 2562999 [No Abstract] [Full Text] [Related]
6. [Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction]. Sárosi I; Debreceni G; Mühl D; Kónyi A; Bogár L; Tekeres M; Tóth K; Habon T; Czopf L; Zámbó K; Schmidt E Orv Hetil; 1997 Aug; 138(31):1939-45. PubMed ID: 9280886 [TBL] [Abstract][Full Text] [Related]
7. [Secondary prevention of myocardial infarction with beta-blockers: for how many?]. Rahav G; Eliakim R; Dror N; Shalev O Harefuah; 1987 Feb; 112(3):116-8. PubMed ID: 2886409 [No Abstract] [Full Text] [Related]
8. [Adrenergic beta receptor blockaders as a secondary prevention after acute myocardial infarction]. Jensen G; Sigurd B Ugeskr Laeger; 1981 Nov; 143(48):3241-5. PubMed ID: 6120594 [No Abstract] [Full Text] [Related]
9. [Secondary prevention following a myocardial infarct]. Enjalbert M; Théroux P; Bourassa MG Union Med Can; 1983 Mar; 112(3):219-20, 225-8, 234. PubMed ID: 6134369 [No Abstract] [Full Text] [Related]
10. [Secondary prevention of myocardial infarct by beta blockers, a myth or reality?]. Vacheron A Ann Med Interne (Paris); 1983; 134(4):286-7. PubMed ID: 6137176 [No Abstract] [Full Text] [Related]
11. [Secondary prevention after myocardial infarction; role of beta blockaders]. Cohen-Solal A; Seknadji P; Czitrom D; Boudvillain O Arch Mal Coeur Vaiss; 1996 Aug; 89 Spec No 3():43-6. PubMed ID: 8949318 [TBL] [Abstract][Full Text] [Related]
12. Identification of high risk patients after an acute myocardial infarction. Therapeutic approach for secondary prevention. Ribeiro LG; Kasdin SL Arq Bras Cardiol; 1985 Mar; 44(3):207-12. PubMed ID: 2868706 [No Abstract] [Full Text] [Related]
13. [Beta receptor blocker in acute myocardial infarct and in secondary prevention]. Werdan K Internist (Berl); 1991 May; 32(5):300-1. PubMed ID: 1678386 [No Abstract] [Full Text] [Related]
14. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use. Dattilo PB; Hailpern SM; Fearon K; Sohal D; Nordin C Ann Emerg Med; 2008 Feb; 51(2):117-25. PubMed ID: 17583376 [TBL] [Abstract][Full Text] [Related]
15. Beta-blockers in the secondary prevention of myocardial infarction: a review of clinical trials of 12 months or more duration. Decorde P Pharmatherapeutica; 1984; 3(8):515-25. PubMed ID: 6142464 [TBL] [Abstract][Full Text] [Related]
16. [Secondary prevention following myocardial infarction]. Kan G; Jaarsma W; Visser CA; Manger Cats V; Lie KI Ned Tijdschr Geneeskd; 1983 Feb; 127(6):257-61. PubMed ID: 6131385 [No Abstract] [Full Text] [Related]
17. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy. Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ; Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652 [TBL] [Abstract][Full Text] [Related]
18. Reducing post-myocardial infarction mortality in the elderly: the power and promise of secondary prevention. Boden WE; Maron DJ J Am Coll Cardiol; 2008 Apr; 51(13):1255-7. PubMed ID: 18371554 [No Abstract] [Full Text] [Related]
19. [Myocardial infarction in elderly patients. Role of beta-adrenoblockers in the treatment and secondary prevention]. Komissarenko IA Ter Arkh; 2003; 75(11):89-93. PubMed ID: 14708453 [No Abstract] [Full Text] [Related]